AMPH Financials
Amphastar Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$20.44
Market Cap
$928.04M
P/E Ratio
9.8
EPS
$2.03
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$731.97M
Gross Profit
-
Operating Income
-
Net Income
$159.52M
EPS (Diluted)
$3.06
Balance Sheet Highlights
Total Assets
$1.58B
Total Liabilities
$845.17M
Shareholders Equity
-
Cash & Equivalents
$151.61M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$213.39M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
49.5%
Operating Margin
0.2%
Net Margin
0.1%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AMPH revenue?
AMPH's most recent quarterly revenue was $731.97M. Annual revenue can be calculated by summing the four most recent quarters.
Is AMPH profitable?
AMPH reported a profit of $159.52M in the most recent quarter. The net profit margin is 0.1%.
What is AMPH market cap?
AMPH has a market capitalization of $928.04M, making it a small-cap stock.
Does AMPH have debt?
View AMPH's balance sheet for debt information.
What is AMPH cash flow?
Cash flow data is available in the full financial statements.